Seqera
Seqera offers a comprehensive bioinformatics platform designed to streamline data analysis for scientific teams. Leveraging their open-source technology, Nextflow, Seqera centralizes data, pipelines, and compute resources under a secure and compliant umbrella. The platform supports integration with existing on-premises systems and major cloud providers (AWS, GCP, Azure) without requiring migrations, ensuring full control over data residency. Seqera's end-to-end solution optimizes workloads from genomics to AI-based drug discovery, facilitating high-throughput, cost-effective computation with robust reproducibility and auditability. It also enhances collaboration across R&D teams by reducing friction and accelerating turnaround times. Seqera is trusted by over 150 leading biotech companies, including 13 of the top 20 global pharmaceutical firms, and its underlying technology, Nextflow, has over 2.43 million monthly runs and is used by over 100,000 global scientists.
Seqera
Seqera offers a comprehensive bioinformatics platform designed to streamline data analysis for scientific teams. Leveraging their open-source technology, Nextflow, Seqera centralizes data, pipelines, and compute resources under a secure and compliant umbrella. The platform supports integration with existing on-premises systems and major cloud providers (AWS, GCP, Azure) without requiring migrations, ensuring full control over data residency. Seqera's end-to-end solution optimizes workloads from genomics to AI-based drug discovery, facilitating high-throughput, cost-effective computation with robust reproducibility and auditability. It also enhances collaboration across R&D teams by reducing friction and accelerating turnaround times. Seqera is trusted by over 150 leading biotech companies, including 13 of the top 20 global pharmaceutical firms, and its underlying technology, Nextflow, has over 2.43 million monthly runs and is used by over 100,000 global scientists.